SCHEMBL8524315

SCHEMBL8524315

O=C1SC(Cc2ccccc2)C(=O)N1OCCn1ccc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.53
PPARG P37231 2/20 0.53
CDK4 P11802 4/20 0.41
CCND1 P24385 4/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
DAO P14920 1/20 0.36
MAPK1 P28482 2/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6032172 0.77 MAPT (0.53) PPARGKDM4EMAPTCYP1A2CYP3A4
SCHEMBL8523430 0.77 MAPT (0.36) FFAR1PPARGKDM4EMAPTHSD17B10
SCHEMBL7512050 0.75 FFAR1 (0.63) FFAR1PPARGCDK4CCND1LMNA
SCHEMBL8523852 0.72 ALDH1A1 (0.44) CDK4CCND1KDM4EMAPTCYP1A2
SCHEMBL8523887 0.71 MAPT (0.43) PPARGKDM4EMAPTCYP1A2CYP3A4
SCHEMBL7469293 0.71 MAPT (0.56) PPARGKDM4EMAPTCYP1A2CYP3A4
SCHEMBL8524317 0.71 FFAR1 (0.44) FFAR1PPARGCDK4CCND1MAPT
SCHEMBL29547028 0.70 FFAR1 (1.00) FFAR1PPARG
SCHEMBL291967 0.70 FFAR1 (1.00) FFAR1PPARG
SCHEMBL8687103 0.70 KDM4E (0.37) PPARGKDM4EMAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US claimed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed